• umbraco.MacroEngines.DynamicXml
    Elevator Pitch

    CEO James Barder

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the Preliminary results for the year ended 31 December 2016

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the significant interest for MED2002, Futura’s erectile dysfunction gel based on Ipsos research

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the UK licensing agreement for its pain relief gel TPR100 and the launch of CSD500 in Saudi Arabia

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the MED2002 opportunity and the appointment of Ken James as head of R&D.

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the £12 million Placing

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the Interim Results and MED2002

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    TTK deal provides "certainty of supply", says Futura chief

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder discussing the MED2002 clinical trial progress

  • umbraco.MacroEngines.DynamicXml
    Video Interview of James Barder

    Video Interview of James Barder - Preliminary results for year ended 31 December 2015

  • umbraco.MacroEngines.DynamicXml
    Shareholder Message

    CEO James Barder gives a shareholder update and outlook on expected news flow for 2016.

  • umbraco.MacroEngines.DynamicXml
    Who We Are

    CEO James Barder introduces Futura Medical and its investment proposition

  • umbraco.MacroEngines.DynamicXml
    Our DermaSys® Technology

    CEO James Barder explains the unique benefits of our transdermal and proprietary technology DermaSys®

  • umbraco.MacroEngines.DynamicXml
    Interview with Proactive Investors

    Futura Medical expects first MED2002 trial study results by June 2016. CEO James Barder is interviewed by Proactive Investors (November 2015)